Taking the Grey Cup to Heart

CP has Heart, the community investment program of railway giant Canadian Pacific (CP), is making a donation to the Peter Munk Cardiac Centre’s Mechanical Heart Program for every touchdown scored through the Canadian Football League playoffs, which culminate in the Grey Cup in Toronto on Nov. 27. (Graphic: CP has Heart)

Regardless of your preferred colours, Canada's annual celebration of football is about to hit a fever pitch with the upcoming Canadian Football League divisional finals this weekend in Ottawa and Calgary. They culminate with thousands of fans from across the country descending on Toronto for the 104th Grey Cup at BMO Field on Sunday, Nov. 27.

The CFL playoffs and final game will have special significant this year for the Peter Munk Cardiac Centre.

Railway giant Canadian Pacific (CP), a sponsor of the CFL, also supports heart-focused initiatives each year through fundraising activities spearheaded by its community investment program, CP has Heart. This year, it has chosen PMCC's Mechanical Heart Program as its beneficiary.

For every touchdown scored during the CFL playoffs, CP has Heart will donate $5,000 to the Mechanical Heart Program. During the Grey Cup, that number doubles to $10,000.

A mechanical heart pump is surgically implanted on or near the heart. It is connected by a drive-line (white cord) inside the body and then exits the body through an incision. The drive-line connects directly to the external battery pack and controller, which keep the mechanical heart operating. (Graphic: PMCC)

There will also be a "​mini-museum​" installation showcasing the evolution of the mechanical heart, with PMCC patients (mechanical heart recipients) and staff on hand as part of Grey Cup Festival activities in downtown Toronto on Friday, Nov. 25 and Saturday, Nov. 26.

The largest of its kind in Canada, the Mechanical Heart Program led by Dr. Vivek Rao, Division Head, Cardiovascular Surgery, began in 2001. It offers leading-edge device therapies — surgically-implanted mechanical heart technology — to severely-ill cardiac patients who meet the strict criteria for this type of treatment option.

Patients enduring the debilitating effects of heart failure are among those for which a mechanical heart — ventricular assist device (VAD) — could provide support, assuming the pumping (of blood) function of the heart.

Dr. Vivek Rao, cardiac surgeon, Peter Munk Cardiac Centre and Division Head, Cardiovascular Surgery, displays a left ventricular assist device (LVAD), the most common of mechanical heart devices, used in about 80 per cent of cases. (Photo: PMCC)

Each device costs about $100,000 per patient, with a fixed number of VADs funded by Ontario's Ministry of Health and Long-Term Care, annually. The rest is supported through philanthropy. In the first decade of the Mechanical Heart Program, more than 25 per cent of all mechanical heart devices were supported through donor funding.

Peter Munk Cardiac Centre surgical teams have implanted more than 200 mechanical hearts to date. They serve as either a critical "bridge to transplant" or increasingly "destination therapy," with some patients even experiencing such significant improvement in their own heart function while on the device that they are eventually able to have the mechanical cardiac device taken out, or explanted.